China and Taiwan look to closer regulatory ties under new cross-strait pact
This article was originally published in Scrip
Executive Summary
China and Taiwan may still have their political differences but they are moving steadily towards increased co-operation and regulatory harmonisation in the pharmaceutical sector under a recent bilateral agreement designed to cut the unnecessary duplication of studies and improve product quality.